Vaccine News and Research

Latest Vaccine News and Research

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

The National Foundation for Infectious Diseases (NFID) issued a new Call to Action report detailing the risks of co-infection with influenza (flu) and COVID-19 in adults with chronic health conditions, and the importance of flu vaccination during the 2020-2021 season.

16 Oct 2020

High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys

As scientists scramble to find effective vaccines and antivirals for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recent study published on the preprint server bioRxiv in October 2020 reports that the use of convalescent plasma to treat COVID-19 disease early in the course of the illness may be among the best available strategies at present.

16 Oct 2020

Sanofi Translate Bio MRT5500 COVID-19 vaccine shows promise in preclinical trials

The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.

16 Oct 2020

Scientists engineer powerful novel anti-microbial molecules from wasp venom

Now, a team of scientists in the Perelman School of Medicine at the University of Pennsylvania has engineered potent novel anti-microbial molecules from toxic proteins found in wasp venom. The researchers believe that the discovery holds promise in fighting the increasing number of antibiotic-resistant bacteria, that cause serious illness.

15 Oct 2020

INRS invests $1 million in COVID-19 research to address society's urgent needs

Quebec is particularly affected by the COVID-19 pandemic. For more than 50 years, Institut national de la recherche scientifique (INRS) has placed research at the service of the development of society, focusing its efforts on strategic issues.

15 Oct 2020

Researchers develop ViDok app to test potential COVID-19 treatments

Anyone with a smartphone can download the app ViDok, which lets users pick from a library of molecules that might bind to key proteins on the SARS-CoV-2 virus, which causes COVID-19, and then can tweak the molecules to try to find a better fit.

15 Oct 2020

SARS-CoV-2 may become endemic if reinfection proves commonplace, say researchers

To date, a few verified repeat SARS-CoV-2 infections have been documented around the world. "Should reinfection [with SARS-CoV-2] prove commonplace, and barring a highly effective vaccine delivered to most of the world's population, SARS-CoV-2 will likely become endemic," write Jeffrey Shaman and Marta Galanti in this Perspective.

15 Oct 2020

Certain live-attenuated vaccines can prevent severe complications of COVID-19

COVID-19 continues to wreak havoc globally, with over one million deaths to date. Yet what if an existing vaccine could make COVID-19 less deadly? A study just published put the theory to test, with promising results.

15 Oct 2020

The COVID-19 vaccine pipeline

Researchers from Mayo Clinic, United States of America, have reviewed the immunity developed against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease.

14 Oct 2020

FDA approves Regeneron antibody drug as first treatment for Ebola virus

Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.

14 Oct 2020

Army researchers team up to test alternative ways to measure COVID-19 antibody levels

Researchers with the U.S. Army Futures Command are part of a team that tested alternative ways to measure COVID-19 antibody levels, resulting in a process that is faster, easier and less expensive to use on a large scale.

14 Oct 2020

Research identifies antigen-specific peripheral T follicular helper cells in COVID-19 infected patients

Researchers have found peripheral T follicular helper cell responses to different structural proteins of SARS-CoV-2 and have studied how the response occurs over time.

14 Oct 2020

Researchers use single cell sequencing technology to characterize immune system of COVID-19 patients

In this study, which was published in the journal Frontiers in Immunology on September 30th, researchers used sequencing to characterize the immune system of patients who survive from COVID-19 infection from symptom onset through recovery.

14 Oct 2020

Many coronavirus strains found in animals can also infect humans, shows study

New research from the University of North Carolina at Chapel Hill suggests that a strain of coronavirus that has recently alarmed the swine industry may have the potential to spread to humans as well.

14 Oct 2020

Study: Public messaging should be communicated before the availability of COVID-19 vaccines

A new study indicates some significant public messaging should be communicated before any COVID-19 vaccines are made available in the US. And with vaccines potentially being approved by the end of the year or early next year, the clock is ticking.

14 Oct 2020

Combining genetic and experimental data can enable more accurate prediction of influenza virus

Combining genetic and experimental data into models about the influenza virus can help predict more accurately which strains will be most common during the next winter, says a study published recently in eLife.

14 Oct 2020

Understanding COVID-19 immunity is crucial for developing vaccination strategies

People who have recovered from COVID-19, and their close contacts, could hold the key to understanding how immunity to the disease develops, how long it lasts and what happens when immunity is lost.

14 Oct 2020

"Pandemic politics" is causing assaults on science and the public health

COVID-19 is now the third leading cause of death in the United States only behind cardiovascular disease and cancer.

14 Oct 2020

Psychologists and sociologists investigate comparative optimism for infection and recovery from COVID-19

Until a vaccine and/or effective cure for COVID-19 becomes available, battling the current pandemic strongly relies on how well people follow behavioral advice, such as adhering to local restrictions, social distancing rules, and engaging in effective personal hygiene.

14 Oct 2020

Probability sampling to slow spread of SARS-CoV-2

Their study titled, “An Innovative Non-Pharmaceutical Intervention to Mitigate SARS-CoV02 Spread: Probability Sampling to Identify and Isolate Asymptomatic Cases,” was released at the pre-publication and pre-peer review site medRxiv*.

14 Oct 2020

Vaccine News and Research

Latest Vaccine News and Research

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys

Sanofi Translate Bio MRT5500 COVID-19 vaccine shows promise in preclinical trials

Scientists engineer powerful novel anti-microbial molecules from wasp venom

INRS invests $1 million in COVID-19 research to address society's urgent needs

Researchers develop ViDok app to test potential COVID-19 treatments

SARS-CoV-2 may become endemic if reinfection proves commonplace, say researchers

Certain live-attenuated vaccines can prevent severe complications of COVID-19

The COVID-19 vaccine pipeline

FDA approves Regeneron antibody drug as first treatment for Ebola virus

Army researchers team up to test alternative ways to measure COVID-19 antibody levels

Research identifies antigen-specific peripheral T follicular helper cells in COVID-19 infected patients

Researchers use single cell sequencing technology to characterize immune system of COVID-19 patients

Many coronavirus strains found in animals can also infect humans, shows study

Study: Public messaging should be communicated before the availability of COVID-19 vaccines

Combining genetic and experimental data can enable more accurate prediction of influenza virus

Understanding COVID-19 immunity is crucial for developing vaccination strategies

"Pandemic politics" is causing assaults on science and the public health

Psychologists and sociologists investigate comparative optimism for infection and recovery from COVID-19

Probability sampling to slow spread of SARS-CoV-2

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in